Holen Sie sich die Stockscreener-App
1.57
8.28%
0.12
Vorhandelsmarkt:
1.57
Schlusskurs vom Vortag:
$1.45
Offen:
$1.45
24-Stunden-Volumen:
2.09M
Relative Volume:
1.85
Marktkapitalisierung:
$96.38M
Einnahmen:
$5.03M
Nettoeinkommen (Verlust:
$-185.41M
KGV:
-0.5081
EPS:
-3.09
Netto-Cashflow:
$-139.79M
1W Leistung:
+12.95%
1M Leistung:
+22.66%
6M Leistung:
-85.62%
1J Leistung:
-87.47%
1-Tages-Spanne:
$1.44
$1.58
1-Wochen-Bereich:
$1.32
$1.58
52-Wochen-Spanne:
$1.1001
$16.10
Pliant Therapeutics Inc Stock (PLRX) Company Profile
Firmenname
Pliant Therapeutics Inc
Sektor
Branche
Telefon
650-481-6770
Adresse
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Vergleichen Sie PLRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLRX
Pliant Therapeutics Inc
|
1.57 | 85.33M | 5.03M | -185.41M | -139.79M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2025-03-04 | Herabstufung | Needham | Buy → Hold |
| 2025-03-03 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-03-03 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-02-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-02-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-02-10 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-05-18 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-04-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-12-14 | Eingeleitet | Stifel | Buy |
| 2022-12-07 | Eingeleitet | JP Morgan | Overweight |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2022-07-20 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-11-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-20 | Eingeleitet | BTIG Research | Buy |
| 2021-04-05 | Eingeleitet | Citigroup | Buy |
| 2020-06-29 | Eingeleitet | Citigroup | Buy |
| 2020-06-29 | Eingeleitet | Cowen | Outperform |
| 2020-06-29 | Eingeleitet | Needham | Buy |
| 2020-06-29 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Pliant Therapeutics Inc Aktie (PLRX) Neueste Nachrichten
Is Pliant Therapeutics Inc. a good long term investmentMarket-beating performance - jammulinksnews.com
What drives Pliant Therapeutics Inc. stock priceFree Expert Stock Watchlist - jammulinksnews.com
What analysts say about Pliant Therapeutics Inc. stockConsistently profitable trades - Autocar Professional
Pliant Therapeutics Inc. Stock Analysis and ForecastHigh-profit trading signals - jammulinksnews.com
Is Pliant Therapeutics Inc. stock a growth or value playHigh Return Potential - Newser
What makes Pliant Therapeutics Inc. stock price move sharplyDefensive Stock Picks with Upside - Newser
3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st
How Pliant Therapeutics Inc. stock performs during market volatilityTrade Ready Signal - Newser
Why Pliant Therapeutics Inc. stock attracts strong analyst attentionLow Risk ROI Maximization - Newser
Pliant Therapeutics Inc (PLRX) Stock: Navigating a Year of Volatility - investchronicle.com
Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Apellis Pharmaceuticals (APLS) and Pliant Therapeutics (PLRX) - The Globe and Mail
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sangamo Biosciences (SGMO), Pliant Therapeutics (PLRX) and Stevanato Group (STVN) - The Globe and Mail
Pliant Therapeutics, Inc.(NasdaqGS: PLRX) dropped from Russell 2500 Index - MarketScreener
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock - The Manila Times
Pliant Therapeutics Provides Update on BEACON-IPF | PLRX Stock News - GuruFocus
Pliant Therapeutics Provides Update on BEACON-IPF - GlobeNewswire
Pliant ends development of idiopathic pulmonary fibrosis asset bexotegrast - Seeking Alpha
Pliant Therapeutics Inc’s (PLRX) Stock Is Harder To Predict Than You Think - Stocksregister
Pliant Therapeutics amends corporate bylaws, holds stockholder vote By Investing.com - Investing.com Nigeria
Pliant Therapeutics amends corporate bylaws, holds stockholder vote - Investing.com
Pliant Therapeutics presents new fibrosis treatment data By Investing.com - Investing.com Canada
Pliant Therapeutics Presents Clinical and Preclinical Data at th - GuruFocus
Pliant Therapeutics presents new fibrosis treatment data - Investing.com
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference | PLRX Stock News - GuruFocus
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society ... - Eagle-Tribune
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference - GlobeNewswire
How Are Things Looking For Pliant Therapeutics Inc (NASDAQ: PLRX) For The Short Term? - Stocksregister
Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties - TipRanks
Another Bay Area biotech company announces layoffs - MSN
Pliant Therapeutics Reports Q1 2025 Financial Results - TipRanks
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - The Manila Times
Pliant (PLRX) Prepares to Release Topline Results from BEACON-IP - GuruFocus
Pliant (PLRX) Prepares to Release Topline Results from BEACON-IPF Trial | PLRX Stock News - GuruFocus
Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):